Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis

Annals of Clinical and Translational Neurology

Volumn 1, Issue 6, 2014, Pages 423-432

  Bonnier, Guillaume ^a,b,c   Roche, Alexis ^a,b,c   Romascano, David ^a,c   Simioni, Samanta ^b   Meskaldji, Djalel ^c   Rotzinger, David ^b   Lin, Ying Chia ^d   Menegaz, Gloria ^d   Schluep, Myriam ^b   Du Pasquier, Renaud ^b   Sumpf, Tilman Johannes ^e   Frahm, Jens ^e   Thiran, Jean Philippe ^c   Krueger, Gunnar ^a,f   Granziera, Cristina ^a,b,c  

^a Advanced Clinical Imaging Technology   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c EPFL   (Switzerland)

^d UNIVERSITY OF VERONA   (Italy)

^e Biomedizinische NMR Forschungs GmbH   (Germany)

^f Siemens Schweiz AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MOTOR PERFORMANCE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TISSUE DEGENERATION; TISSUE INJURY;

EID: 84925209491     PISSN: None     EISSN: 23289503     Source Type: Journal    
DOI: 10.1002/acn3.68     Document Type: Article

References (54)

1. Filippi M. Multiple sclerosis: a white matter disease with associated gray matter damage. J Neurol Sci 2001;185:3–4.
2. Calabrese M, Filippi M, Gallo P. Cortical lesions in multiple sclerosis. Nature Rev Neurol 2010;6:438–444.
3. Rocca MA, Messina R, Filippi M. Multiple sclerosis imaging: recent advances. J Neurol 2013;260:929–935.
4. Deoni SC. Magnetic resonance relaxation and quantitative measurement in the brain. Methods Mol Biol 2011;711:65–108.
5. Alexander AL, Hurley SA, Samsonov AA, et al. Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains. Brain Connect 2011;1:423–446.
6. Neema M, Goldberg-Zimring D, Guss ZD, et al. 3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis. NeuroImage 2009;46:633–641.
7. Catalaa I, Grossman RI, Kolson DL, et al. Multiple sclerosis: magnetization transfer histogram analysis of segmented normal-appearing white matter. Radiology 2000;216:351–355.
8. Bakshi R, Benedict RH, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002;59:62–68.
9. Levesque IR, Giacomini PS, Narayanan S, et al. Quantitative magnetization transfer and myelin water imaging of the evolution of acute multiple sclerosis lesions. Magn Reson Med 2010;63:633–640.
10. Tardif CL, Bedell BJ, Eskildsen SF, et al. Quantitative magnetic resonance imaging of cortical multiple sclerosis pathology. Mult Scler Int 2012;2012:742018.
11. Sumpf TJ, Uecker M, Boretius S, Frahm J. Model-based nonlinear inverse reconstruction for T2 mapping using highly undersampled spin-echo MRI. J Magn Reson Imaging 2011;34:420–428.
12. Marques JP, Kober T, Krueger G, et al. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. NeuroImage 2010;49:1271–1281.
13. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685–691.
14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361–370.
15. Penner IK, Raselli C, Stocklin M, et al. The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue. Mult Scler 2009;15:1509–1517.
16. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–1452.
17. Fischer JS, Rudick RA, Cutter GR, Reingold SC. The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force. Mult Scler 1999;5:244–250.
18. Granziera C, Romascano D, Daducci A, et al. Migraineurs without aura show microstructural abnormalities in the cerebellum and frontal lobe. Cerebellum 2013;12:812–818.
19. Granziera C, Daducci A, Simioni S, et al. Micro-structural brain alterations in aviremic HIV+ patients with minor neurocognitive disorders: a multi-contrast study at high field. PLoS One 2013;8:e72547.
20. Granziera C, Daducci A, Romascano D, et al. Structural abnormalities in the thalamus of migraineurs with aura: A multiparametric study at 3 T. Hum Brain Mapp. 2013;12:812–818.
21. Robson PM, Grant AK, Madhuranthakam AJ, et al. Comprehensive quantification of signal-to-noise ratio and g-factor for image-based and k-space-based parallel imaging reconstructions. Magn Reson Med 2008;60:895–907.
22. Wiens CN, Kisch SJ, Willig-Onwuachi JD, McKenzie CA. Computationally rapid method of estimating signal-to-noise ratio for phased array image reconstructions. Magn Reson Med 2011;66:1192–1197.
23. Kober T, Granziera C, Ribes D, et al. MP2RAGE multiple sclerosis magnetic resonance imaging at 3 T. Invest Radiol 2012;47:346–352.
24. Helms G, Draganski B, Frackowiak R, et al. Improved segmentation of deep brain grey matter structures using magnetization transfer (MT) parameter maps. NeuroImage 2009;47:194–198.
25. Yablonskiy DA, Sukstanskii AL, Luo J, Wang X. Voxel spread function method for correction of magnetic field inhomogeneity effects in quantitative gradient-echo-based MRI. Magn Reson Med 2013;70:1283–1292.
26. Fatnassi C, Krueger G, Meuli R, O'Brien KR. 2013. Non linear correction of R2*maps from Macroscopic Field Inhomogeneities. Toulouse, France: ESMRMB.
27. Irarrazabal P, Meyer CH, Nishimura DG, Macovski A. Inhomogeneity correction using an estimated linear field map. Magn Reson Med 1996;35:278–282.
28. An H, Lin W. Impact of intravascular signal on quantitative measures of cerebral oxygen extraction and blood volume under normo- and hypercapnic conditions using an asymmetric spin echo approach. Magn Reson Med 2003;50:708–716.
29. Ogg RJ, Steen RG. Age-related changes in brain T1 are correlated with iron concentration. Magn Reson Med 1998;40:749–753.
30. Schenker C, Meier D, Wichmann W, et al. Age distribution and iron dependency of the T2 relaxation time in the globus pallidus and putamen. Neuroradiology 1993;35:119–124.
31. Ropele S, de Graaf W, Khalil M, et al. MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging 2011;34:13–21.
32. Grossman RI. Magnetization transfer in multiple sclerosis. Ann Neurol 1994;36(Suppl):S97–S99.
33. Klein S, Staring M, Murphy K, et al. elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 2010;29:196–205.
34. Roche A, Ribes D, Bach-Cuadra M, Kruger G. On the convergence of EM-like algorithms for image segmentation using Markov random fields. Med Image Anal 2011;15:830–839.
35. Hasan KM, Walimuni IS, Kramer LA, Narayana PA. Human brain iron mapping using atlas-based T2 relaxometry. Magn Reson Med 2012;67:731–739.
36. Georgiades CS, Itoh R, Golay X, et al. MR imaging of the human brain at 1.5 T: regional variations in transverse relaxation rates in the cerebral cortex. AJNR Am J Neuroradiol 2001;22:1732–1737.
37. DeLuca J, Johnson SK, Beldowicz D, Natelson BH. Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression. J Neurol Neurosurg Psychiatry 1995;58:38–43.
38. Phillips LJ, Stuifbergen AK. The relevance of depressive symptoms and social support to disability in women with multiple sclerosis or fibromyalgia. Int J Rehabil Res 2010;33:142–150.
39. Osborne JW. Improving your data transformations: applying Box-Cox transformations as a best practice. Pract Assess Res Eval 2010;15:1–9.
40. Haacke EM, Makki M, Ge Y, et al. Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging. J Magn Reson Imaging 2009;29:537–544.
41. Whittall KP, MacKay AL, Li DK, et al. Normal-appearing white matter in multiple sclerosis has heterogeneous, diffusely prolonged T(2). Magn Reson Med 2002;47:403–408.
42. De Stefano N, Battaglini M, Stromillo ML, et al. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain. 2006;129(Pt 8):2008–2016.
43. Griffin CM, Chard DT, Parker GJ, et al. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis. J Neurol 2002;249:193–199.
44. Vavasour IM, Laule C, Li DK, et al. Is the magnetization transfer ratio a marker for myelin in multiple sclerosis? J Magn Reson Imaging 2011;33:713–718.
45. Rashid W, Hadjiprocopis A, Davies G, et al. Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging. J Neurol 2008;255:390–397.
46. Yu CS, Lin FC, Liu Y, et al. Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis. Eur J Radiol 2008;68:328–334.
47. Moll NM, Rietsch AM, Thomas S, et al. Multiple sclerosis normal-appearing white matter: pathology-imaging correlations. Ann Neurol 2011;70:764–773.
48. Reich DS, Smith SA, Zackowski KM, et al. Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. NeuroImage 2007;38:271–279.
49. Hasan KM, Walimuni IS, Abid H, et al. Multi-modal quantitative MRI investigation of brain tissue neurodegeneration in multiple sclerosis. J Magn Reson Imaging 2012;35:1300–1311.
50. Sati P, Cross AH, Luo J, et al. In vivo quantitative evaluation of brain tissue damage in multiple sclerosis using gradient echo plural contrast imaging technique. NeuroImage 2010;51:1089–1097.
51. Luo J, Yablonskiy DA, Hildebolt CF, et al. Gradient echo magnetic resonance imaging correlates with clinical measures and allows visualization of veins within multiple sclerosis lesions. Multiple sclerosis. 2013;20:349–355.
52. Lassmann H. Pathology and disease mechanisms in different stages of multiple sclerosis. J Neurol Sci 2013;333:1–4.
53. Batista S, Zivadinov R, Hoogs M, et al. Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012;259:139–146.
54. Nielsen AS, Kinkel RP, Madigan N, et al. Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology 2013;81:641–649.